Karl W Siebe, MD | |
116 Lakeview Dr, Noblesville, IN 46060-1307 | |
(317) 773-7400 | |
(317) 773-9029 |
Full Name | Karl W Siebe |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 39 Years |
Location | 116 Lakeview Dr, Noblesville, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184699068 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 01034180A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Karl W Siebe, MD 116 Lakeview Dr, Noblesville, IN 46060-1307 Ph: (317) 773-7400 | Karl W Siebe, MD 116 Lakeview Dr, Noblesville, IN 46060-1307 Ph: (317) 773-7400 |
News Archive
A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has been cleared by the U.S. Food and Drug Administration (FDA). The
Boston University School of Medicine (BUSM) researchers recently uncovered a brain signaling pathway responsible for regulating the renal excretion of sodium. The findings appear in the Journal of the Federation of American Societies for Experimental Biology.
Minority women tend to be less aware of the increased risk of cardiovascular disease they face by being overweight or obese. The results of a study that compared Hispanic and non-Hispanic white women based on their knowledge of heart disease risk factors and their perceptions of their own weight is published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
Pfizer said today that Eraxis (anidulafungin) has been approved by the U.S. Food and Drug Administration to treat candidemia, a potentially life-threatening bloodstream infection. Candidemia is the most deadly of the common hospital-acquired bloodstream infections, with a mortality rate of approximately 40 percent.
› Verified 4 days ago